课题基金 / 基金详情

Cardioprotection during hypertensive heart disease is mediated through anti-viral cytokine pathways

Cardioprotection during hypertensive heart disease is mediated through anti-viral cytokine pathways
高血压心脏病期间的心脏保护是通过抗病毒细胞因子途径介导的
批准号:
461883
负责人:
Epelman Slava
金额:
$66.6万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
未结题
起止时间:
2022-03-01 至 2027-03-01

项目摘要

项目成果

Epelman Slava的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
High blood pressure is a common risk factor for patients to develop a weak and/or stiff heart. When the heart develops problematic changes in response to high blood pressure, heart failure can occur - a condition with a poor prognosis. We have unexpectant
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Differential type I interferon responses drive sex-specific vulnerability to viral myocarditis
  • 批准号:
    487141
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2023
  • 负责人:
    Epelman Slava
  • 依托单位:
Differential type I interferon responses drive sex-specific vulnerability to viral myocarditis
  • 批准号:
    488319
  • 项目类别:
    Operating Grants
  • 资助金额:
    $66.32万
  • 财政年份:
    2023
  • 负责人:
    Epelman Slava
  • 依托单位:
An unexpected role for type I Interferon underlies cardiac adaptation to stress and prevents heart failure
  • 批准号:
    444878
  • 项目类别:
    Operating Grants
  • 资助金额:
    $66.32万
  • 财政年份:
    2021
  • 负责人:
    Epelman Slava
  • 依托单位:
Cerebrovascular-immune interfaces: searching for an immune signature coupling hypertension to cognitive dysfunction (ImmuneHyperCog).
  • 批准号:
    425187
  • 项目类别:
    Operating Grants
  • 资助金额:
    $21.86万
  • 财政年份:
    2020
  • 负责人:
    Epelman Slava
  • 依托单位:
海外基金